Figure 1.
Carbenoxolone inhibits VACV replication in a gap junction-independent manner. Cells ((A) HaCaT and (C) N2a) were untreated or treated with different concentrations of CBX and then infected with VACV-A5L-EGFP (MOI = 0.1). Virus levels were determined by fluorescence. Results of untreated cells and cells treated with 30 µM CBX were analysed by t test, *** denotes p < 0.05. Cell viability ((B) HaCaT and (D) N2a) was defined by CellTiter-Blue ® assay. Non-treated cells were designated as 100% viability. IC50 and CC50 values (48 h p.i.) are noted. Experiments are representative of two independent replicates performed in triplicate. Error bars = standard deviation.